Selumetinib MEK inhibitor  

     

Select             pdf
Trial Studied trt Control trt patientstagsROB Trial resultdeath (overall survival) progression or death (progression free survival PFS)

melanoma  

Kirkwood, 2012     selumetinibtemozolomide -
Kirkwood   selumetinibtemozolomide -